Sun Pharmaceutical Of India Sued By France's Sanofi Over Allegra Patent
This article was originally published in PharmAsia News
Executive Summary
India's Sun Pharmaceutical is being sued by French maker Sanofi-Aventis to block a generic version of the Allegra (fexofenadine) drug to treat allergies. The suit was filed in a U.S. court because Sun applied for FDA approval of its generic before the Sanofi patent expires. Sun already faces another Sanofi suit filed in August to protect the patent for its Taxotere (docetaxel) cancer drug. (Click here for more